CovalX Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $384K
Latest Deal Amount
  • Investors
  • 3

CovalX General Information

Description

Operator of a biotechnology company intended to provide technology and services in the field of protein interaction analysis based on mass spectrometry. The company develops innovative analysis alternatives for the characterization of therapeutic proteins and protein interactions for the life science industry, enabling pharmaceutical companies, life science industries and academic laboratories to achieve high-quality results for the analysis of protein complexes, antibodies and therapeutic proteins.

Contact Information

Website
www.covalx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Primary Office
  • Schützengasse 23
  • 8001 Zürich
  • Switzerland
+41 044 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CovalX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 23-Aug-2011 $384K 00.000 Completed Generating Revenue
1. Early Stage VC 09-Jun-2008 00.000 00.000 00.000 Completed Generating Revenue
To view CovalX’s complete valuation and funding history, request access »

CovalX Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view CovalX’s complete cap table history, request access »

CovalX Executive Team (4)

Name Title Board Seat Contact Info
Alexis Nazabal Ph.D Co-Founder, Chief Executive Officer, Director of European & Asia Operations & Board Member
Ryan Wenzel Ph.D Co-Founder, Vice Chairman, Director of North American Operations & Board Member
Jason Sumner Executive
Urs Matter Co-Founder
To view CovalX’s complete executive team members history, request access »

CovalX Board Members (3)

Name Representing Role Since
Mario Hochstrasser CovalX Board Member 000 0000
Philip Bodmer CovalX Chairman 000 0000
Ryan Wenzel Ph.D CovalX Co-Founder, Vice Chairman, Director of North American Operations & Board Member 000 0000
To view CovalX’s complete board members history, request access »

CovalX Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CovalX Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Commission for Technology and Innovation Government Minority 000 0000 000000 0
BioBac Angel Group Minority 000 0000 000000 0
StartAngels Network Angel Group Minority 000 0000 000000 0
To view CovalX’s complete investors history, request access »